FDA to Host Public Workshop on Regulation of Whole Blood and Blood Components, Including Source Plasma, Seeks Comments on Proposed Rule

Summary

The Food and Drug Administration (FDA) is hosting a public workshop to discuss its proposed regulation of whole blood and blood components, including source plasma, and is seeking comments on the proposed rule, which aims to improve the licensure and regulation of these products